Literature DB >> 34636197

Effect of RhoE expression on the migration and invasion of tongue squamous cell carcinoma.

Kai Zhao1, Wen-Hong Yuan2, Wen-Jian Li3, Zeng-Peng Chi4, Shao-Ru Wang3, Zheng-Gang Chen2.   

Abstract

OBJECTIVES: This study aims to investigate the effect of RhoE expression on the migration and invasion of tongue squamous cell carcinoma (TSCC).
METHODS: Forty-eight TSCC cases were selected from the Maxillofacial Surgery Center of Qingdao Municipal Hospital from 2017 to 2019. The expression of RhoE in the specimens (TSCC and adjacent tissues) was detected by immunohistochemistry, and RhoE mRNA and protein were extracted to further detect the expression of RhoE. SCC-4 and CAL-27 cells were selected for in vitro experiments. Transient transfection was used to overexpress RhoE. Real-time fluorescence quantitative PCR (qRT-PCR) and Western blot analyses were conducted to detect the overexpression efficiency. Scratch test and Transwell cell invasion tests were used to detect the migration and invasion ability of TSCC, respectively. The expression levels of Rho-associated coiled-coil-containing protein kinase 1 (ROCK1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) were detected by Western blot. Experimental data were analyzed by Graphpad prism 8.2.1 software.
RESULTS: The expression level of RhoE in TSCC was significantly lower than that in adjacent tissues (P<0.05). The migration and invasion abilities of TSCC were significantly lower than those in the control group (P<0.05). The Western blot showed significantly lower expression levels of ROCK1, MMP-2, and MMP-9 in the experimental group than in the control group (P<0.05).
CONCLUSIONS: RhoE expression is low in TSCC. Over expression RhoE in TSCC can significantly decrease its migration and invasion abilities. Hence, RhoE may play an important role in regulating the metastasis and invasion of TSCC and provide a new target for gene therapy.

Entities:  

Keywords:  RhoE; invasion; migration; tongue squamous cell carcinoma

Mesh:

Substances:

Year:  2021        PMID: 34636197      PMCID: PMC8548219          DOI: 10.7518/hxkq.2021.05.003

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  23 in total

Review 1.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation.

Authors:  R Foster; K Q Hu; Y Lu; K M Nolan; J Thissen; J Settleman
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

3.  Rnd3/RhoE expression is regulated by G-actin through MKL1-SRF signaling pathway.

Authors:  Léo Piquet; Terezinha Robbe; Véronique Neaud; Sara Basbous; Stéphanie Rosciglione; Frédéric Saltel; Violaine Moreau
Journal:  Exp Cell Res       Date:  2018-06-22       Impact factor: 3.905

4.  Predicting Radiotherapy Necessity in Tongue Cancer Using Lymph Node Yield.

Authors:  Zhien Feng; Qiao Shi Xu; Li Zheng Qin; Hua Li; Zhengxue Han
Journal:  J Oral Maxillofac Surg       Date:  2016-10-14       Impact factor: 1.895

5.  Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia.

Authors:  Jinfeng Zhou; Kai Li; Yong Gu; Bin Feng; Gui Ren; Liyun Zhang; Yafang Wang; Yongzhan Nie; Daiming Fan
Journal:  Biochem Biophys Res Commun       Date:  2011-10-19       Impact factor: 3.575

6.  Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression.

Authors:  Philippe Riou; Priam Villalonga; Anne J Ridley
Journal:  Bioessays       Date:  2010-09-10       Impact factor: 4.345

Review 7.  Rnd3 in Cancer: A Review of the Evidence for Tumor Promoter or Suppressor.

Authors:  Lisa Paysan; Léo Piquet; Frédéric Saltel; Violaine Moreau
Journal:  Mol Cancer Res       Date:  2016-08-23       Impact factor: 5.852

8.  A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma.

Authors:  Dan J Raz; M Roshni Ray; Jae Y Kim; Biao He; Miquel Taron; Marcin Skrzypski; Mark Segal; David R Gandara; Rafael Rosell; David M Jablons
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

9.  Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.

Authors:  Cristina Belgiovine; Roberta Frapolli; Katiuscia Bonezzi; Ilaria Chiodi; Francesco Favero; Maurizia Mello-Grand; Angelo P Dei Tos; Elena Giulotto; Giulia Taraboletti; Maurizio D'Incalci; Chiara Mondello
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  Knockdown of RhoE Expression Enhances TGF-β-Induced EMT (epithelial-to-mesenchymal transition) in Cervical Cancer HeLa Cells.

Authors:  Makoto Nishizuka; Rina Komada; Masayoshi Imagawa
Journal:  Int J Mol Sci       Date:  2019-09-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.